Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Turkey (Türkiye)

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Turkey (Türkiye) Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20091
20101
20111
20121
20132
20161
20171
20181
20193
20233
20242
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting5
Recruiting5
Terminated5
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
AstraZeneca3
Eli Lilly and Company3
GlaxoSmithKline2
Pfizer2
United Therapeutics2
Alnylam Pharmaceuticals1
Boehringer Ingelheim1
CSL Behring1
Esperion Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases27
Stroke8
Myocardial Infarction7
Hypertension6
Atherosclerosis5
Hyperlipidemias5
Diabetes Mellitus, Type 24
Heart Diseases4
Heart Failure4
Acute Coronary Syndrome3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.